Please login to the form below

Not currently logged in
Email:
Password:

dengue vaccine

This page shows the latest dengue vaccine news and features for those working in and with pharma, biotech and healthcare.

Sanofi’s latecomer PD-1 gets date for FDA verdict

Sanofi’s latecomer PD-1 gets date for FDA verdict

blockbuster Lantus (insulin glargine) and a poor start for dengue vaccine Dengvaxia.

Latest news

  • Sanofi warns of difficult few months as diabetes sales slump Sanofi warns of difficult few months as diabetes sales slump

    Overall, sales for the quarter were down nearly 9% to just under 8bn, with cancer and cardiovascular drugs and vaccines also underperforming, the latter because of the safety problems with dengue ... vaccine Dengvaxia and supply issues for paediatric

  • Sanofi confirms suspected safety issue with dengue vaccine Sanofi confirms suspected safety issue with dengue vaccine

    Sanofi confirms suspected safety issue with dengue vaccine. As rival Takeda conduct phase II testing for its own dengue vaccine candidate. ... The setbacks for Dengvaxia provide an opportunity for rival Takeda to leapfrog Sanofi with its own dengue

  • Takeda dengue vaccine data looks good as it chases Sanofi Takeda dengue vaccine data looks good as it chases Sanofi

    Takeda dengue vaccine data looks good as it chases Sanofi. TAK-003 achieved a 71% reduction in developing the virus compared to placebo. ... Takeda’s chances of stealing a march on rival Sanofi in the dengue fever vaccine market look increasingly high

  • Takeda plans German plant to support dengue vaccine roll-out Takeda plans German plant to support dengue vaccine roll-out

    Takeda plans German plant to support dengue vaccine roll-out. Will invest more than 100m in the Singen manufacturing facility. ... Our colleagues in Singen have vast experience in lyophilisation technology, which is key for the manufacturing process of

  • Sanofi takeover bid rebuffed by Medivation Sanofi takeover bid rebuffed by Medivation

    However, it is going through a fertile stage at present, with recent approvals for cholesterol drug Praluent (alirocumab) and dengue fever vaccine Dengvaxia and new diabetes hope LixiLan (lixisenatide/insulin glargine)

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics